GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pfizer PFE · USD

Health Care · Pharmaceuticals · US listing · 🇺🇸 United States

S&P 500

Compare

29.23

-0.54%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Pfizer

Our reporting

Next results

2 Feb 2027

Due on 2 Feb 2027. Analysts expect earnings of 0.72 a share on revenue of $17.08bn.

Past results

Reported against what analysts expected

3 Nov 20264 Aug 20265 May 20263 Feb 20264 Nov 20255 Aug 2025
Earnings per share0.870.770.750.660.870.78
Forecast0.730.680.720.570.630.58
Revenue$16.58bn$15.03bn$14.45bn$17.56bn$16.65bn$14.65bn
Forecast$15.85bn$14.40bn$13.84bn$16.85bn$16.50bn$13.56bn

Key events

  1. 24 Jun 20131-to-1 reverse split
  2. 1 Jul 19993-for-1 share split
  3. 1 Jul 19972-for-1 share split
  4. 3 Jul 19952-for-1 share split
  5. 1 Apr 19912-for-1 share split
  6. 17 Jan 1944Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.